Aigen Sciences

AI-based drug discovery and designing tool for researchers

placeSeoul, Seoul, South Korea calendar_todayFounded 2021 groups8 employees language aigensciences.com

Innovation

8 patent families — focus: Chemistry & metallurgy, Physics & computing; filing pace active. Cited 45 times.

YearFilings
20258

Investor mix

7 investors on record.

Investor typeCountShare
Venture capital343%
Private equity229%
Other / undisclosed229%
Coming soon